Objectives
After participating in this educational activity, attendees should be able to:
- Understand the pathophysiology of the different types of heart failure including decompensated heart failure
- Briefly review the guideline recommended pharmacologic treatments for HFrEF and DHF
- Analyze the VICTORIA trial in order to determine the role of vericiguat in the treatment of HFrEF
Faculty
Clara Forbes, PharmD
PGY1 Pharmacy Resident
Pharmacist
Baystate Medical Center
Faculty Disclosure
The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
None of the other planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Accreditation Statement
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
- 1.00 ACPE Contact Hours
- 1.00 BCIPE Instructional Hours